Menu
GeneBe

MRPL39

mitochondrial ribosomal protein L39, the group of Large subunit mitochondrial ribosomal proteins|Mitochondrial ribosomal proteins

Basic information

Region (hg38): 21:25585655-25607517

Links

ENSG00000154719NCBI:54148OMIM:611845HGNC:14027Uniprot:Q9NYK5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial disease (Moderate), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MRPL39 gene.

  • Inborn genetic diseases (15 variants)
  • Leigh syndrome (2 variants)
  • Combined oxidative phosphorylation deficiency 59 (2 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRPL39 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
14
clinvar
14
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
clinvar
1
clinvar
3
Total 0 2 15 0 1

Highest pathogenic variant AF is 0.000125

Variants in MRPL39

This is a list of pathogenic ClinVar variants found in the MRPL39 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
21-25587768-G-C not specified Uncertain significance (Apr 11, 2023)2518239
21-25592807-C-T Leigh syndrome • Combined oxidative phosphorylation deficiency 59 Pathogenic/Likely pathogenic (Dec 05, 2023)1676672
21-25592837-C-A Mitochondrial disease • Combined oxidative phosphorylation deficiency 59 Likely pathogenic (Feb 04, 2021)1525985
21-25592891-G-A not specified Uncertain significance (Jan 26, 2022)2273099
21-25592951-A-G not specified Uncertain significance (Jun 13, 2023)2520789
21-25593918-G-C not specified Uncertain significance (Nov 17, 2022)2407456
21-25593941-A-G not specified Uncertain significance (Oct 25, 2023)3207759
21-25597305-C-A not specified Uncertain significance (Aug 04, 2023)2616490
21-25597366-C-T not specified Uncertain significance (Aug 13, 2021)2244891
21-25597371-T-C not specified Uncertain significance (Jun 11, 2021)2396984
21-25597380-G-A not specified Uncertain significance (Mar 27, 2023)2514119
21-25598338-C-T Leigh syndrome • Combined oxidative phosphorylation deficiency 59 Likely pathogenic (Jun 24, 2022)1676674
21-25599832-C-A not specified Uncertain significance (Jun 09, 2022)2357929
21-25599860-GA-G Leigh syndrome • Combined oxidative phosphorylation deficiency 59 Likely pathogenic (Jun 24, 2022)1676673
21-25601389-C-T not specified Uncertain significance (Jan 18, 2022)2271853
21-25601445-A-G not specified Uncertain significance (May 17, 2023)2547673
21-25601452-A-T not specified Uncertain significance (Feb 06, 2024)3207738
21-25603803-A-G not specified Uncertain significance (Jan 26, 2022)2209336
21-25603928-G-C not specified Uncertain significance (May 18, 2022)2407002
21-25606461-T-A not specified Uncertain significance (Feb 28, 2024)3207732
21-25606509-C-T not specified Uncertain significance (Apr 03, 2023)2532248
21-25606523-T-C not specified Uncertain significance (Feb 09, 2023)2482630
21-25606638-A-A Benign (Dec 31, 2019)769210

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MRPL39protein_codingprotein_codingENST00000307301 1121862
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000004310.9591256710771257480.000306
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3732061911.080.000009792297
Missense in Polyphen5053.4660.93518711
Synonymous-0.7717466.01.120.00000348647
Loss of Function1.901221.50.5570.00000118263

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006310.000623
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0003970.000396
Middle Eastern0.00005440.0000544
South Asian0.0003660.000359
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Pathway
Mitochondrial translation initiation;Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation termination;Mitochondrial translation (Consensus)

Recessive Scores

pRec
0.114

Intolerance Scores

loftool
0.874
rvis_EVS
0.22
rvis_percentile_EVS
68.44

Haploinsufficiency Scores

pHI
0.149
hipred
N
hipred_score
0.196
ghis
0.563

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.587

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mrpl39
Phenotype

Gene ontology

Biological process
mitochondrial translational elongation;mitochondrial translational termination
Cellular component
mitochondrion;mitochondrial inner membrane;mitochondrial ribosome;mitochondrial large ribosomal subunit
Molecular function
nucleotide binding;RNA binding